Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle
© Rinnankoski-Tuikka et al.; licensee BioMed Central Ltd. 2012
Received: 21 March 2012
Accepted: 9 June 2012
Published: 9 June 2012
The expression of PDK4 is elevated by diabetes, fasting and other conditions associated with the switch from the utilization of glucose to fatty acids as an energy source. It is previously shown that peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a master regulator of energy metabolism, coactivates in cell lines pyruvate dehydrogenase kinase-4 (PDK4) gene expression via the estrogen-related receptor α (ERRα). We investigated the effects of long-term high-fat diet and physical activity on the expression of PDK4, PGC-1α and ERRα and the amount and function of mitochondria in skeletal muscle.
Insulin resistance was induced by a high-fat (HF) diet for 19 weeks in C57BL/6 J mice, which were either sedentary or with access to running wheels. The skeletal muscle expression levels of PDK4, PGC-1α and ERRα were measured and the quality and quantity of mitochondrial function was assessed.
The HF mice were more insulin-resistant than the low-fat (LF) -fed mice. Upregulation of PDK4 and ERRα mRNA and protein levels were seen after the HF diet, and when combined with running even more profound effects on the mRNA expression levels were observed. Chronic HF feeding and voluntary running did not have significant effects on PGC-1α mRNA or protein levels. No remarkable difference was found in the amount or function of mitochondria.
Our results support the view that insulin resistance is not mediated by the decreased qualitative or quantitative properties of mitochondria. Instead, the role of PDK4 should be contemplated as a possible contributor to high-fat diet-induced insulin resistance.
A multitude of studies have postulated that obesity and the metabolic syndrome caused by sedentary lifestyle and western diet decrease the capacity of skeletal muscles to oxidize the accumulated lipids [1, 2]. Previously this has been proposed to occur by decreased mitochondrial content as well as mitochondrial biogenesis and function [[3, 4, 5, 6, 7, 8] suggesting an association between mitochondrial dysfunction and insulin resistance, the qualitative and quantitative changes in mitochondria being potentially the ultimate cause [9, 10]. However, recent studies have convincingly shown that high-fat diet actually increases mitochondrial biogenesis and fatty acid oxidative capacity in skeletal muscle [11–13] and that lipid-induced insulin resistance in the absence of physical activity is strongly associated to incomplete β-oxidation and mitochondrial overload or “mitochondrial stress” . Mitochondrial defects per se, e.g. deficient electron transport chain, do not seem to be the cause of insulin resistance .
Although reduced muscle mitochondrial content and function have been proposed to be a consequence of physical inactivity and sedentary lifestyle, exercise efficiently stimulates muscle oxidative capacity and thus corrects the imbalance between fatty acid uptake and oxidation [16–18]. Furthermore, physical activity reduces the reliance on carbohydrates, thus increasing the proportion of fatty acids used as an energy source and enhancing muscle fatty acid oxidation, especially during submaximal exercise [19, 20].Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a potential main regulator of the metabolic program that has been shown to be acutely activated by exercise training and down-regulated by high-fat feeding and sedentary lifestyle . PGC-1α has known roles in mitochondrial biogenesis and fatty acid oxidation. The ability of PGC-1α to co-activate the orphan nuclear receptor ERRα (estrogen- related receptor) results in the activation of a broad mitochondrial program, including the induction of oxidative phosphorylation and mitochondrial biogenesis [22–25]. It has been demonstrated both in humans  and in rodents [27, 28] that the expression of PGC-1α is induced by exercise [29, 30] after the activation of PGC-1α promoter . Despite the many functions of PGC-1α in overall energy homeostasis, its function as a potential regulator in glucose utilization pathways is not well characterized .
The pyruvate dehydrogenase kinases (PDKs) regulate the activity of pyruvate dehydrogenase complex (PDC), which catalyzes the oxidative decarboxylation of pyruvate in the glucose oxidation process. The isoform PDK4 is highly expressed in liver, heart and skeletal muscle and is regulated by exercise. Its expression is elevated with diabetes, fasting and other conditions associated with the switch from the utilization of glucose to fatty acids as an energy source [32, 33]. It has been suggested that insulin resistance is associated with dysregulation of the PDC in skeletal muscle and that excess insulin would on the other hand down-regulate the expression of PDK4 [25, 34, 35]. Interestingly, transcription factor ERRα and transcriptional co- activator PGC-1α both induce PDK4 gene expression independently [31, 36]. In addition, it has been shown that PGC-1α is recruited to the PDK4 promoter by ERRα, which stimulates further the expression of PDK4 [31, 37, 38]. Our primary aim was to study the effects of high-fat diet and physical activity on the expression of PDK4 and aspects of its regulation. We hypothesized that when dietary carbohydrates are replaced by fatty acids as a fuel for oxidation in muscle, the expression of PDK4 is increased, and this elevation is regulated by the PGC-1α/ERRα-pathway. Secondly, we studied the effect of high-fat diet and physical activity on the amount and function of mitochondria in skeletal muscle.
Animals and diets
Male C57BL/6 J mice (n = 58) were obtained from Taconic (Ejby, Denmark) at the age of 6 weeks and were individually housed in standard conditions (temperature 22°C, humidity 50 ± 10%, light from 8:00 am to 8:00 pm). After one week of adaptation to new environment, the mice were matched for body-weight (20.8 ± 1.4 g) and divided into four groups. The mice received for 19 weeks ad libitum either a lard- based purified high-fat diet (61% of energy from fat, 19% protein, 20% carbohydrates 5.16 kcal/g; D12492-Euro) to induce obesity and insulin resistance, or a low-fat diet as a control diet (10% of energy from fat, 19% protein, 71% carbohydrates, 3.78kcal/g; D12450-Euro, Purina Mills TestDiet®, PMI® Nutrition International,Richmond, IN, USA). The nutritional profile of the fat content of the two diets was as follows (high-fat diet/low-fat diet): cholesterol 229/18 ppm, linoleic acid 3.97/1.39%, linolenic acid 0.36/0.19%, arachidonic acid 0.05/0.00%, omega-3 fatty acid 0.36/0.19%, total saturated fatty acids 10.54/1.14%, total monounsaturated fatty acids 10.84/1.30%. The groups of low-fat fed (LF) or high-fat fed (HF) mice were either sedentary (LFsed or HFsed) or physically active (LFexe or HFexe) throughout the experiment. Mice were housed individually in cages and the physically active mice had access to a running wheel, as previously described . The amount of running was monitored via a computerized system across the study period. All mice were weighed and food consumption was monitored at three-week intervals. Feeding efficiency was calculated (weight gained in mg per kilocalories consumed), but no numerical results are presented and only significant differences are mentioned in the results. The protocols were approved by the Animal Care and Use Committee of the University of Jyväskylä.
After overnight fasting, a blood sample was collected at intervention weeks 9 and 18 and the blood glucose level was determined (HemoCue, Ängelholm, Sweden). Insulin was analyzed with an Ultra Sensitive Rat Insulin ELISA Kit according to manufacturer’s protocol (Crystal Chem Inc., Downers Grove, IL, USA). Insulin resistance was estimated by multiplying the fasting values of glucose and insulin. Triglycerides, total cholesterol and free fatty acids were measured from the end-point serum samples, of which triglycerides and cholesterol were measured using the VITROS DT60 II Chemistry System (Ortho-Clinical Diagnostics, Rochester, NY, USA). The Wako NEFA C test kit (Wako Chemicals GmbH, Neuss, Germany) scaled down to a microplate format was used to determine free fatty acids (FFA).
RNA extraction and cDNA synthesis
Total RNA was isolated from (approximately 50 mg of) the gastrocnemius with Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer’s instructions. Muscle samples were homogenized with a FastPrep (Bio101 Systems, USA) tissue homogenizer by using Lysing Matrix D (Q-Biogene, USA). The concentration and purity of RNA were determined photometrically at wavelengths of 260 nm and 280 nm. The integrity of RNA was checked with agarose gel electrophoresis. Five micrograms of total RNA was reverse transcribed to synthesize cDNA (SuperScript III Reverse Transcriptase kit, Invitrogen). For efficient mRNA transcription, a mixture of oligo primers (Oligomer, Helsinki, Finland), consisting of 20 dT residues followed by two additional nucleotides, which anneal only at the 5’ end of the poly(A) tail of mRNA, was used.
Real-time quantitative PCR
The mRNA expression levels of ERRα, PCG-1α and PDK4 were determined with the ABI 7300 Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). The TaqMan primer and probe sets were designed and synthesized by Applied Biosystems. The gene bank accession numbers and Applied Biosystems assay IDs, respectively were: NM_007953.2 and Mm00433142_m1 (ERRα), NM_008904.1 and Mm01208833_m1 (PGC-1α), NM_013743.2 and Mm00443326_m1 (PDK4). The PCR cycle parameters used were: +50°C for 2 min, +95°C for 10 min, 40 cycles at +95°C for 15 s, and +60°C for 1 min. All samples were analyzed in triplicate. The gene expressions were normalized using a Quant-iT™ PicoGreen® assay (Invitrogen) according to manufacturer’s instructions. The PicoGreen method was used to quantitate the total amount of RNA-cDNA-hybrids from the solution of reverse- transcribed mRNA products .
The QF muscle samples were hand-homogenized in 4% homogenization buffer [10% SDS (w/v), 40 mM DTT, 5 mM EDTA, 0.1 M Tris–HCl pH 8 and protease inhibitors 40 μg/ml aprotinin, 80 μg/ml PMSF and 40 μg/ml leupeptin (Sigma, Saint Louis, USA)]. Western immunoblot analyses from the muscle lysates (samples containing 20 μg of total protein) were done as previously described [41,42]. Briefly, PVDF membranes were incubated overnight at 4°C with rabbit primary antibodies against PGC-1α (1:1000, Calbiochem, Merck KGaA, Darmstadt, Germany), PDK4 and ERRα (1:1200 and 1:3000 respectively, Novus Biologicals, Littleton, CO, USA), and with goat antibody against cytochrome c (CytC, 1:2000 Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Membranes were incubated with horseradish peroxidase- conjugated secondary anti-rabbit or anti-goat IgG antibody (Jackson ImmunoResearch Laboratories, PA, USA) diluted 1:50 000 or 1:70 000, respectively, in TBS-Tween (0.1%) with 2.5% milk for 1 h followed by washing in TBS-T. Preliminary experiments confirmed a proportional linear relationship between protein loaded and, especially, Ponceau S but also α-actin (1:20 000, Sigma) in quantification between 5 and 60 μg, demonstrating the suitability of Ponceau S to be used as a method to control for loading . Proteins were visualized by ECL according to manufacturer's protocol (SuperSignal West femto maximum sensitivity substrate, Pierce Biotechnology, Rockford, IL, USA) and quantified using ChemiDoc XRS Quantity One software (version 4.6.3. Bio-Rad, UK).
Image analysis of SDH activity
Serial cross-sections (8 μm) from the QF muscle were cut in a cryomicrotome (−25°C). The activity of succinate dehydrogenase (SDH) was used as a marker for muscle fiber oxidative capacity as described by Pette and Tyler .
The SDH-stained cross-sections (n = 4-12 animals/group) were captured in full color using light microscopy (Olympus BX-50, Olympus Optical, Tokyo, Japan). Digitally captured images (magnification 20 x) with a minimum of three fields-of-view per muscle cross-section were processed and analyzed using ImageJ software (NIH, Bethesda, MD, USA). The images were converted to 8-bit gray-scale (range of grey levels 0–255) images. An intensity threshold representing minimal intensity values corresponding to SDH activity was set manually and uniformly used for all images (least oxidative gray levels 46–90; most oxidative 140–255). The three intensity scaled fractions representing different oxidative capacities of fibers were expressed as the percentage of the measured area.
Electron microscopic analysis of mitochondrial content
Pieces of soleus (n = 5 animals/group) were fixed with 3% glutaraldehyde in 0.1 M phosphate buffer for 2–2.5 h at +4°C, and post-fixed with 1% osmium tetroxide in the same buffer at +4°C for 1 h. The specimens were stained in uranyl acetate, dehydrated in ethanol and embedded in LX-112 (Ladd). Semithin sections were cut, stained with toluidine blue and examined with light microscope to optimize the transverse orientation. Thereafter, ultrathin sections were cut, mounted on grids and stained with uranyl acetate and lead citrate. Micrographs were taken from the best section of each block with a Jeol JEM-1200 electron microscope at 2500 x primary magnification. It was checked that micrographs were taken from different cells (10–13 cells/section) and that sarcolemmal areas were included. In total 343 micrographs were analyzed using AnalySIS software (Olympus). The amount of subsarcolemmal mitochondria was expressed as mitochondrial area (μm2) and related to the length of sarcolemma (μm).
Measurements of mitochondrial respiration
The homogenization of QF muscle samples and isolation for the mitochondrial respiration measurements was done mainly according to Wardlaw et al. with minor modifications. Briefly, mitochondrial respiration rates (30 μl of freshly prepared mitochondria) were measured at 25°C with a Clark-type oxygen electrode (Hansatech Instruments Ltd, England) in a reaction medium. Respiration rates were recorded in the presence of complex I substrates pyruvate (5 mM) and malate (2.5 mM). State 3 respiration was initiated by adding 150 mM ADP (1.5 mM in buffer). Oxygen consumption was related to the protein content of the suspension determined in triplicates according to manufacturer’s instructions (BCA assay kit, Pierce). Mitochondrial respiration rates in the QF muscle homogenates were measured using the same procedure as the respiration of isolated mitochondria.
All data are presented as mean ± SD. A repeated general linear model was used with weight gain, feeding efficiency and weekly running distance as parameters. Two-way ANOVA was used to determine the effect of diet (with 2 levels: low-fat diet and high- fat diet), exercise (with 2 levels: with and without voluntary running), and their interaction with the measured variables, as previously described . Differences between the means of the intervention groups were evaluated, and the significance of differences was determined by Bonferroni post hoc testing. All statistical analyses were carried out using PASW statistics software release 18.0 (IBM Corporation, Armonk, NY, USA). Differences of P < 0.05 were considered significant.
Food consumption, body mass and tissue weight
32.6 ± 2.86
29.2 ± 1.72**
45.4 ± 5.29***
44.4 ± 3.12***,¤¤¤
799.13 ± 345.1
424.04 ± 65.4*
1767.38 ± 383.2***
1925.06 ± 541.0***,¤¤¤
144.98 ± 12.6
141.12 ± 7.7
151.34 ± 8.6
154.81 ± 7.4**,¤¤¤
Quadriceps femoris (mg)
206.53 ± 10.1
211.35 ± 11.8
220.61 ± 13.0**
228.23 ± 11.0***,¤¤¤
12.96 ± 1.4
12.47 ± 1.1
13.19 ± 1.7
12.83 ± 1.1
10.85 ± 1.6
11.81 ± 1.3
11.14 ± 1.2
13.80 ± 1.6***,§§§,¤¤¤
Feeding efficiency varied in the different groups throughout the experiment. The feeding efficiency values of the HF mice ranged from 16.75 ± 4.55 mg/kcal to 7.55 ± 4.15 mg/kcal during the three-week monitoring intervals, and were significantly higher than those of the LF mice (9.78 ± 2.25 mg/kcal and 3.85 ± 3.18 mg/kcal, respectively). Running induced a slight decrease in feeding efficiency in the LF mice.
After four weeks of running, both the LF and HF groups reached their maximum weekly running distance, which then decreased gradually (Figure 2B). Consistent differences in the weekly running distance were observed after 12 weeks, the running distance of LF mice being significantly higher than that of HF mice. However, no statistically significant difference between the groups in total cumulative running distance (LF 422 ± 108 km, HF 339 ± 136 km) was observed.
Blood glucose, insulin and lipid profile
Blood profiles of the mice after the 19-week experiment
Total cholesterol (mmol/l)#
2.99 ± 0.88
2.70 ± 0.36
4.90 ± 0.54***
4.52 ± 0.49***,¤¤¤
0.97 ± 0.23
1.05 ± 0.21
1.00 ± 0.24
0.90 ± 0.13¤
Free fatty acids (mmol/l)
0.82 ± 0.15
0.92 ± 0.16
0.49 ± 0.13***
0.44 ± 0.12***,¤¤¤
Fasting glucose (mmol/l)
8.92 ± 1.17
8.45 ± 0.90
9.39 ± 1.12
10.53 ± 0.72***,§§,¤¤¤
Fasting insulin (ng/ml)#
0.43 ± 0.24
0.27 ± 0.16*
2.25 ± 1.11***
2.14 ± 0.82***,¤¤¤
The high-fat diet had an effect on total cholesterol and on free fatty acids (FFA), the cholesterol levels being higher and, somewhat unexpectedly, the FFA levels lower in the HF groups (Table 2). The HFexe and LFexe groups also differed in total cholesterol, FFA and triglyceride levels.
Although the change was most pronounced in PDK4, also PGC-1α (Figure 5B) and ERRα (Figure 5C) proteins showed a similar trend: both running and high-fat feeding increased the expression of each protein, but high-fat feeding combined with running had no additive effect on the protein expressions (no difference between the HF groups). PGC-1α expression showed a slight, although not statistically significant, effect for diet and for running. Exercise increased the expression of ERRα in the LF mice (P < 0.05).
Skeletal muscle oxidative capacity
Oxidative capacity estimated by SDH staining
SDH stain intensity
Least oxidative (%)
32.5 ± 18.0
39.4 ± 15.2
49.8 ± 18.4
30.3 ± 26.2
42.8 ± 12.3
35.8 ± 7.3
33.4 ± 11.8
39.0 ± 15.6
Most oxidative (%)
24.7 ± 8.7
24.8 ± 11.1
16.8 ± 7.8
30.7 ± 16.8§
In the present study we observed concomitantly with explicit insulin resistance an up- regulated PDK4 expression along with less prominent ERRα expression in response to the high-fat diet and/or to voluntary exercise. We also found that high-fat diet did not alter the oxidative capacity of isolated mitochondria or oxygen consumption in the muscle homogenate. Voluntary running exercise improved insulin sensitivity during the first 9 weeks of the high-fat diet, but no longer after 18 weeks, concomitantly with decreased running activity. The effects of exercise on the mitochondrial parameters were comparable or greater to those of the high-fat diet, but in most cases exercise and high-fat diet did not have additional/synergistic effects.
In addition to its ability to exert effects on oxidative metabolism in muscle , it has been suggested that PGC-1α controls skeletal muscle glucose metabolism by increasing the amount of PDK4 via a PGC-1α/ERRα-dependent mechanism . This is further supported by the finding that ERRα recruits PGC-1α to the PDK4 promoter [37, 38]. Our results show distinct effects of high-fat diet and voluntary running on PDK4 protein expression and, more elaborately, an additive effect of both HF diet and voluntary running on mRNA expression but not on protein expression. Although we did not measure the activity of PDC in our experiment, it is known that PDK4 negatively regulates the PDC, thus inhibiting the entry of pyruvate to the Krebs cycle . In addition, PDK4 has been found to be a contributor to lipid-induced changes of glucose metabolism in rodent and human studies [47–49]. We speculate that increased PDK4 expression after high-fat feeding and exercise is due to previous increase in PGC-1α and ERRα expression, which subsequently blunts cellular glucose oxidation. Our results suggest that in addition to molecular and cellular level in vitro, PGC- 1α/ERRα-dependent regulation of PDK4 expression also may operate in vivo in skeletal muscle.
Previous studies have demonstrated that a high-fat diet can increase the biogenesis of mitochondria and fatty acid oxidative capacity in skeletal muscle [12, 13]. It can be suggested that not only in the state of increased energy demand, such as exercise, but also in the case of constantly increased energy supply with high fatty acid availability, the oxidation of fatty acids can be intensified. This paradigm is supported by the present data, which shows improved total mitochondrial capacity in response to a high-fat diet for 19 weeks. These results contradict previous findings according to which a high-fat diet decreases the capacity of muscles to oxidize the accumulated lipids [1, 2], which would occur owing to the decreased number of mitochondria, as reported in the offspring of type 2 diabetic parents .
PGC-1α is considered the master regulator that coordinates the gene expression of oxidative metabolism as well as mitochondrial biogenesis in skeletal muscle [50, 51]. In our study the effect of chronic high-fat feeding for 19 weeks had no effect on the expression of PGC-1α. This is in contrast to a previous study that showed decreased PGC-1α expression in muscle after 1 week on a HF diet that persisted down-regulated over 11 weeks . In other studies a high-fat diet for 4–5 weeks has even increased muscle PGC-1α protein expression and the number of mitochondria [11, 12]. These discrepancies may be partly due to differences in the fatty acid compositions of the diets, since it has been shown that, depending on their chain length and saturation level, fatty acids have greatly varying effects on PGC-1α expression . PGC-1α mRNA and protein expression peak rapidly after a stimulus, such as an exercise bout [14, 26, 29] or an increase in the concentration of serum fatty acids . After a period of adaptation, no change or only slight changes in PGC-1α mRNA and protein levels have been observed, after 4 weeks of high-fat diet  or, as in the present study, after a high-fat diet and/or exercise for 19 weeks. In addition to PGC-1α, ERRα, acting downstream of PGC-1α, is also a critical transcriptional regulator of mitochondrial biogenesis and cellular energy metabolism [24, 28, 31]. Moreover, ERRα is expressed in tissues demonstrating a high capacity for fatty acid β-oxidation [54, 55]. In this study, we found a significant increase in ERRα mRNA expression after a high-fat diet combined with voluntary running, and in protein expression after a low-fat diet combined with running. We believe that the modest changes observed in PGC-1α and ERRα expression are remnants of previous high increases caused by every single exercise bout and/or dietary fatty acids. A limitation to our study is that we measured only the transcript levels of PGC-1α, but not alternative regulatory mechanisms. PGC-1α activity is also regulated by protein modifications, including phosphorylation, acetylation and ubiqitination .
High-fat feeding declines general physical activity in rodents [57, 58]. Similarly, in this study high-fat feeding induced consistent reduction of wheel-running after 12 weeks of diet, although at the end of the experiment cumulative running distances did not statistically differ between LF and HF mice. Access to running wheels increases general cage activity and affect several components of energy balance (reviewed in Novak et al. ) that may have effects to the regulation of muscle metabolism. However, it is not possible to dissect the effects of these factors in this study. In this study the HF mice with or without exercise were severely insulin resistant, as indicated by their increased levels of fasting insulin and glucose, suggesting that they had developed a metabolic condition resembling metabolic syndrome or type 2 diabetes . In our experiment, we found the plasma free fatty acid concentration to be significantly lower in the HF animals compared to LF animals. Conceivably, skeletal muscle had adapted to the chronic high-fat diet to be able to better extract and oxidize circulating lipids. The preference for fatty acids as an energy source is reflected in elevated blood glucose. Our data may suggest that both in chronic high-fat diet and in long-term exercise training, the switch of fuel usage from glucose to fatty acids is mediated by the elevated expression of PDK4. It is known that during long-term exercise or short-term fasting, the activity of PDC is attenuated in conjunction with increased fatty acid usage . Accordingly, the expression of PDK4 is increased in fasting, diabetes and other conditions associated with switching from glucose oxidation to fatty acid oxidation .
What is the mechanism behind high-fat diet-induced insulin resistance? It has been shown that chronic high-fat diet-induced insulin resistance, unlike insulin resistance induced by acute increase in plasma free fatty acids (i.e. Randle glucose fatty acid cycle), is not rapidly reversible . On the basis of our studies, we agree that most probably it is not the decrease in the amount or intrinsic function of mitochondria that leads to increased intramyocellular lipids [12, 13]. Our data on insulin resistance and normal mitochondrial function support the idea that lipids themselves or metabolites of lipid metabolism attribute to impaired response to insulin, e.g. via altered cell membrane properties  or by affecting IRS phosphorylation and GLUT4 translocation . Our data further suggest that the inhibition of pyruvate dehydrogenase by PDK4 is a possible contributor to insulin resistance. In this scenario high-fat diet-induced insulin resistance may be a consequence of the continuing regulatory process of PGC-1α/ERRα activated by chronic high fatty acid availability. Our data also show that voluntary running exercise improved insulin resistance only transiently during the 19-week high-fat diet, implying that the regulatory power of fatty acids is superior to exercise. On the other hand, the inability of exercise to improve insulin sensitivity after the 19 weeks of wheel running in the experiment might be due to the reduced amount of running during the latter half of the experiment. The role of fatty acids in insulin resistance is a complex process, with some fatty acids inducing and others reversing skeletal muscle insulin resistance , suggesting that a balanced fatty acid composition in the diet would be beneficial for optimal muscle cell metabolism and function.
We conclude that a chronic high-fat diet does not have a negative effect on muscle mitochondrial function in spite of severe insulin resistance. This finding suggests that, contrary to frequent allegation, insulin resistance is not mediated by the decreased qualitative or quantitative properties of mitochondria. Instead, our data suggest that the role of PDK4 should be contemplated as a possible contributor to high-fat diet- induced insulin resistance.
We acknowledge the valuable work of Aila Ollikainen and the other lab technicians. Raija Vassinen and Sunna Lappalainen are thanked for their help in the cutting of the EM samples. Paavo Niutanen is acknowledged for his help with the electron micrographs. The Finnish Ministry of Education and Culture, LIKES Foundation for Sport and Health Sciences, National Doctoral Programme of Musculoskeletal Disorders and Biomaterials (TBDP), and Academy of Finland are acknowledged for their financial support.
- Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002, 51: 2944-2950. 10.2337/diabetes.51.10.2944.View ArticleGoogle Scholar
- Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patientswith type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia. 2007, 50: 113-120.View ArticleGoogle Scholar
- Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, Nair KS: Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes. 2006, 55: 3309-3319. 10.2337/db05-1230.View ArticleGoogle Scholar
- Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J: Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Investig. 2008, 118: 789-800.Google Scholar
- Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterso N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003, 34: 267-273. 10.1038/ng1180.View ArticleGoogle Scholar
- Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004, 350: 664-671. 10.1056/NEJMoa031314.View ArticleGoogle Scholar
- Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005, 54: 8-14. 10.2337/diabetes.54.1.8.View ArticleGoogle Scholar
- Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR: A high- fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes. 2005, 54: 1926-1933. 10.2337/diabetes.54.7.1926.View ArticleGoogle Scholar
- Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science. 2005, 307: 384-387. 10.1126/science.1104343.View ArticleGoogle Scholar
- Morino K, Petersen KF, Shulman GI: Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 2006, 55 (Suppl 2): S9-S15.View ArticleGoogle Scholar
- Garcia-Roves P, Huss JM, Han DH, Hancock CR, Iglesias-Gutierrez E, Chen M, Holloszy JO: Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci U S A. 2007, 104: 10709-10713. 10.1073/pnas.0704024104.View ArticleGoogle Scholar
- Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO: High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A. 2008, 105: 7815-7820. 10.1073/pnas.0802057105.View ArticleGoogle Scholar
- Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ: Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes. 2007, 56: 2085-2092. 10.2337/db07-0093.View ArticleGoogle Scholar
- Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, Dohm GL, Yan Z, Newgard CB, Muoio DM: Peroxisome proliferator-activated receptor-gamma co- activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 2005, 280: 33588-33598. 10.1074/jbc.M507621200.View ArticleGoogle Scholar
- Han DH, Hancock CR, Jung SR, Higashida K, Kim SH, Holloszy JO: Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance. PLoS One. 2011, 6: e19739-10.1371/journal.pone.0019739.View ArticleGoogle Scholar
- Hegarty BD, Turner N, Cooney GJ, Kraegen EW: Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. Acta Physiol (Oxf). 2009, 196: 129-145. 10.1111/j.1748-1716.2009.01968.x.View ArticleGoogle Scholar
- Holloszy JO: Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr. 2009, 89: 463S-466S.View ArticleGoogle Scholar
- Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE: Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes. 2007, 56: 2142-2147. 10.2337/db07-0141.View ArticleGoogle Scholar
- Goodpaster BH, Brown NF: Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise?. Exerc Sport Sci Rev. 2005, 33: 150-154. 10.1097/00003677-200507000-00008.View ArticleGoogle Scholar
- van Aggel-Leijssen DP, Saris WH, Wagenmakers AJ, Senden JM, van Baak MA: Effect of exercise training at different intensities on fat metabolism of obese men. J Appl Physiol. 2002, 92: 1300-1309.View ArticleGoogle Scholar
- Benton CR, Wright DC, Bonen A: PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab. 2008, 33: 843-862. 10.1139/H08-074.View ArticleGoogle Scholar
- Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM: An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A. 2003, 100: 7111-7116. 10.1073/pnas.1232352100.View ArticleGoogle Scholar
- Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, Willy PJ, Schulman IG, Heyman RA, Lander ES, Spiegelman BM: Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A. 2004, 101: 6570-6575. 10.1073/pnas.0401401101.View ArticleGoogle Scholar
- Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, Oakeley EJ, Kralli A: The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A. 2004, 101: 6472-6477. 10.1073/pnas.0308686101.View ArticleGoogle Scholar
- Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA: Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes. 1999, 48: 1593-1599. 10.2337/diabetes.48.8.1593.View ArticleGoogle Scholar
- Pilegaard H, Saltin B, Neufer PD: Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol. 2003, 546: 851-858. 10.1113/jphysiol.2002.034850.View ArticleGoogle Scholar
- Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z: Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem. 2005, 280: 19587-19593. 10.1074/jbc.M408862200.View ArticleGoogle Scholar
- Wright DC, Han DH, Garcia-Roves PM, Geiger PC, Jones TE, Holloszy JO: Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem. 2007, 282: 194-199.View ArticleGoogle Scholar
- Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO: Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J. 2002, 16: 1879-1886. 10.1096/fj.02-0367com.View ArticleGoogle Scholar
- Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T, Tabata I: Effects of low- intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun. 2002, 296: 350-354. 10.1016/S0006-291X(02)00881-1.View ArticleGoogle Scholar
- Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP: PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol. 2005, 25: 10684-10694. 10.1128/MCB.25.24.10684-10694.2005.View ArticleGoogle Scholar
- Connaughton S, Chowdhury F, Attia RR, Song S, Zhang Y, Elam MB, Cook GA, Park EA: Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol. 2010, 315: 159-167. 10.1016/j.mce.2009.08.011.View ArticleGoogle Scholar
- Feige JN, Auwerx J: Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007, 17: 292-301. 10.1016/j.tcb.2007.04.001.View ArticleGoogle Scholar
- Kiilerich K, Gudmundsson M, Birk JB, Lundby C, Taudorf S, Plomgaard P, Saltin B, Pedersen PA, Wojtaszewski JF, Pilegaard H: Low muscle glycogen and elevated plasma free fatty acid modify but do not prevent exercise-induced PDH activation in human skeletal muscle. Diabetes. 2010, 59: 26-32. 10.2337/db09-1032.View ArticleGoogle Scholar
- Majer M, Popov KM, Harris RA, Bogardus C, Prochazka M: Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab. 1998, 65: 181-186. 10.1006/mgme.1998.2748.View ArticleGoogle Scholar
- Pilegaard H, Neufer PD: Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc. 2004, 63: 221-226. 10.1079/PNS2004345.View ArticleGoogle Scholar
- Araki M, Motojima K: Identification of ERRalpha as a specific partner of PGC-1alpha for the activation of PDK4 gene expression in muscle. FEBS J. 2006, 273: 1669-1680. 10.1111/j.1742-4658.2006.05183.x.View ArticleGoogle Scholar
- Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F, McDonnell DP, Unterman TG, Elam MB, Park EA: Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem. 2006, 281: 39897-39906. 10.1074/jbc.M608657200.View ArticleGoogle Scholar
- Ma H, Torvinen S, Silvennoinen M, Rinnankoski-Tuikka R, Kainulainen H, Morko J, Peng Z, Kujala UM, Rahkila P, Suominen H: Effects of diet-induced obesity and voluntary wheel running on bone properties in young male C57BL/6 J mice. Calcif Tissue Int. 2010, 86: 411-419. 10.1007/s00223-010-9346-3.View ArticleGoogle Scholar
- Lundby C, Nordsborg N, Kusuhara K, Kristensen KM, Neufer PD, Pilegaard H: Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies. Eur J Appl Physiol. 2005, 95: 351-360. 10.1007/s00421-005-0022-7.View ArticleGoogle Scholar
- Hulmi JJ, Tannerstedt J, Selanne H, Kainulainen H, Kovanen V, Mero AA: Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men. J Appl Physiol. 2009, 106: 1720-1729. 10.1152/japplphysiol.00087.2009.View ArticleGoogle Scholar
- Hulmi JJ, Silvennoinen M, Lehti M, Kivela R, Kainulainen H: Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy. Am J Physiol Endocrinol Metab. 2012, 302: E307-E315. 10.1152/ajpendo.00398.2011.View ArticleGoogle Scholar
- Pette D, Tyler KR: Response of succinate dehydrogenase activity in fibres of rabbit tibialis anterior muscle to chronic nerve stimulation. J Physiol. 1983, 338: 1-9.View ArticleGoogle Scholar
- Wardlaw GM, Kaplan ML: Oxygen consumption and oxidative capacity of muscles from young obese and nonobese Zucker rats. Am J Physiol. 1984, 247: R911-R917.Google Scholar
- Spiegelman BM: Transcriptional control of energy homeostasis through the PGC1 coactivators. Novartis Found Symp. 2007, 286: 196-203. 3–6; discusssion 6–12, 162–3Google Scholar
- Sugden MC, Holness MJ: Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem. 2006, 112: 139-149. 10.1080/13813450600935263.View ArticleGoogle Scholar
- Chokkalingam K, Jewell K, Norton L, Littlewood J, van Loon LJ, Mansell P, Macdonald IA, Tsintzas K: High-fat/low carbohydrate diet reduces insulin- stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: An important role for skeletal muscle pyruvate dehydrogenase kinase 4. J Clin Endocrinol Metab. 2007, 92: 284-292.View ArticleGoogle Scholar
- Holness MJ, Kraus A, Harris RA, Sugden MC: Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high- fat feeding. Diabetes. 2000, 49: 775-781. 10.2337/diabetes.49.5.775.View ArticleGoogle Scholar
- Hoy AJ, Brandon AE, Turner N, Watt MJ, Bruce CR, Cooney GJ, Kraegen EW: Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am J Physiol Endocrinol Metab. 2009, 297: E67-E75. 10.1152/ajpendo.90945.2008.View ArticleGoogle Scholar
- Jager S, Handschin C, St-Pierre J, Spiegelman BM: AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A. 2007, 104: 12017-12022. 10.1073/pnas.0705070104.View ArticleGoogle Scholar
- Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999, 98: 115-124. 10.1016/S0092-8674(00)80611-X.View ArticleGoogle Scholar
- Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME: Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem. 2007, 282: 15439-15450. 10.1074/jbc.M611214200.View ArticleGoogle Scholar
- Rodriguez AM, Sanchez J, Tobaruela A, Priego T, Pico C, Palou A: Time-course effects of increased fatty acid supply on the expression of genes involved in lipid/glucose metabolism in muscle cells. Cell Physiol Biochem. 2010, 25: 337-346. 10.1159/000276566.View ArticleGoogle Scholar
- Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V: Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol. 2003, 23: 7947-7956. 10.1128/MCB.23.22.7947-7956.2003.View ArticleGoogle Scholar
- Sladek R, Bader JA, Giguere V: The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol. 1997, 17: 5400-5409.Google Scholar
- Fernandez-Marcos PJ, Auwerx J, Giguere V: Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 2001, 93:Google Scholar
- Bjursell M, Gerdin AK, Lelliott CJ, Egecioglu E, Elmgren A, Tornell J, Oscarsson J, Bohlooly-Y M: Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. Am J Physiol Endocrinol Metab. 2008, 294: E251-E260.View ArticleGoogle Scholar
- Novak CM, Kotz CM, Levine JA: Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet resistant rats. Am J Physiol Endocrinol Metab. 2006, 290: E396-E403.View ArticleGoogle Scholar
- Novak CM, Burghardt PR, Levine JA: The use of a running wheel to measure activity in rodents: relationship to energy balance, general activity, and reward. Neurosci Biobehav Rev. 2012, 36: 1001-1014. 10.1016/j.neubiorev.2011.12.012.View ArticleGoogle Scholar
- Han DH, Hansen PA, Host HH, Holloszy JO: Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes. 1997, 46: 1761-1767. 10.2337/diabetes.46.11.1761.View ArticleGoogle Scholar
- Roche TE, Hiromasa Y: Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci. 2007, 64: 830-849. 10.1007/s00018-007-6380-z.View ArticleGoogle Scholar
- Wu P, Blair PV, Sato J, Jaskiewicz J, Popov KM, Harris RA: Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys. 2000, 381: 1-7. 10.1006/abbi.2000.1946.View ArticleGoogle Scholar
- Han DH, Hancock C, Jung SR, Holloszy JO: Is “fat-induced” muscle insulin resistance rapidly reversible?. Am J Physiol Endocrinol Metab. 2009, 297: E236-E241. 10.1152/ajpendo.00244.2009.View ArticleGoogle Scholar
- Ikonen E, Vainio S: Lipid microdomains and insulin resistance: is there a connection. Science's STKE. 2005, 2005: pe3-10.1126/stke.2682005pe3.Google Scholar
- Galuska D, Ryder J, Kawano Y, Charron MJ, Zierath JR: Insulin signaling and glucose transport in insulin resistant skeletal muscle. Special reference to GLUT4 transgenic and GLUT4 knockout mice. Adv Exp Med Biol. 1998, 441: 73-85.View ArticleGoogle Scholar
- Coll T, Jove M, Rodriguez-Calvo R, Eyre E, Palomer X, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M: Palmitate mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes. 2006, 55: 2779-2787. 10.2337/db05-1494.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.